Compare · EVH vs RTO
EVH vs RTO
Side-by-side comparison of Evolent Health Inc (EVH) and Rentokil Initial plc (RTO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EVH and RTO operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- RTO is the larger of the two at $7.51B, about 16.0x EVH ($469.0M).
- Over the past year, EVH is down 45.1% and RTO is up 22.3% - RTO leads by 67.3 points.
- RTO has been more active in the news (2 items in the past 4 weeks vs 1 for EVH).
- EVH has more recent analyst coverage (19 ratings vs 12 for RTO).
- Company
- Evolent Health Inc
- Rentokil Initial plc
- Price
- $4.17+5.58%
- $29.82-1.03%
- Market cap
- $469.0M
- $7.51B
- 1M return
- +11.07%
- -11.96%
- 1Y return
- -45.05%
- +22.26%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NYSE
- NYSE
- IPO
- 2015
- 2022
- News (4w)
- 1
- 2
- Recent ratings
- 19
- 12
Evolent Health Inc
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Latest EVH
- Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer
- SEC Form 10-Q filed by Evolent Health Inc
- Evolent Health Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Evolent Announces First Quarter 2026 Results
- SEC Form DEF 14A filed by Evolent Health Inc
- SEC Form DEFA14A filed by Evolent Health Inc
- Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Evolent Health Inc
- Evolent announces appointment of Archie Mayani as chief product officer
- Foodsmart Appoints Cityblock Health Co-Founder and CEO Dr. Toyin Ajayi to Board of Directors
Latest RTO
- SEC Form SD filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- Terminix Debuts New Podcast to Help Businesses Mitigate Operational Risk
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc
- New York City Replaces Los Angeles as America's Most Mosquito‑Infested City, New Terminix Data Reveals
- SEC Form 6-K filed by Rentokil Initial plc
- SEC Form 6-K filed by Rentokil Initial plc